Abb Vie beats second-quarter estimates but lowers full-year adjusted EPS outlook
AbbVie reported second-quarter net revenue of $16.99 billion, compared with estimates of $16.77 billion. Second-quarter adjusted earnings per share were $3.65, versus estimates of $3.61. AbbVie expects full-year adjusted earnings per share of $13.87 to $14.07, down from its previous outlook of $13.91 to $14.11. AbbVie shares fell nearly 3% in premarket trading.
AbbVie reported second-quarter net revenue of $16.99 billion, compared with estimates of $16.77 billion.
Second-quarter adjusted earnings per share were $3.65, versus estimates of $3.61.
AbbVie expects full-year adjusted earnings per share of $13.87 to $14.07, down from its previous outlook of $13.91 to $14.11.
AbbVie shares fell nearly 3% in premarket trading.
Second-quarter adjusted earnings per share were $3.65, versus estimates of $3.61.
AbbVie expects full-year adjusted earnings per share of $13.87 to $14.07, down from its previous outlook of $13.91 to $14.11.
AbbVie shares fell nearly 3% in premarket trading.